Enbrel
Biological response modifiers (BRMs) are medicines or biological agents that modify the activity of the immune system to regulate inflammation, immune responses and disease progression. They are commonly used in the treatment of autoimmune disorders, inflammatory diseases and certain cancers. BRMs include monoclonal antibodies, recombinant proteins, cytokines, interferons, interleukins and immune checkpoint inhibitors. Examples include adalimumab, infliximab, rituximab, etanercept and interferon alfa. Depending on their mechanism of action, these medicines may block inflammatory cytokines, suppress specific immune cells or stimulate immune activity against abnormal cells.